Company intelligence / Profile preview

Bota Bio

Lafayette, California, USAbota.bio ↗

Ownership: Private
Employees: ~34
Development stage: Commercial

Overview

Bota Bio has successfully commercialized its biomanufacturing technology through strategic partnerships such as with NHU. Its end-to-end synthetic biology platform enables the efficient transition from lab-scale innovation to industrial-scale production of sustainable ingredients used in nutrition and personal care. The company’s pilot plant supports rapid scale-up and market-ready product delivery across multiple industries.

Therapeutic areas: Other
Modalities: Engineered microbes for biosynthesisIndustrial fermentationProtein engineering
Industry: Non-Drug Biotech

Partnerships

NHU Group Co., Ltd.—strategic partnership/commercialization partner in specialty chemicals & fermentation strains.BASF Venture Capital—investor and possible strategic partner.

Beyond the preview

Go deeper on Bota Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bota Bio.

Explore the full profile